| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 67.533 | 105.214 | 86.023 | 87.957 | 95.676 | 102.590 | 106.718 | 111.261 | 125.995 | 134.453 |
| Total Income - EUR | 68.350 | 105.214 | 86.023 | 88.601 | 95.676 | 102.590 | 106.718 | 111.299 | 127.694 | 134.453 |
| Total Expenses - EUR | 61.833 | 92.039 | 74.751 | 76.753 | 88.296 | 96.739 | 100.146 | 103.199 | 136.906 | 124.725 |
| Gross Profit/Loss - EUR | 6.517 | 13.174 | 11.272 | 11.848 | 7.379 | 5.851 | 6.573 | 8.099 | -9.212 | 9.729 |
| Net Profit/Loss - EUR | 5.474 | 11.175 | 10.810 | 10.969 | 6.422 | 4.901 | 5.505 | 6.987 | -10.489 | 8.170 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Pivalexim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 18.262 | 12.258 | 26.462 | 20.995 | 14.482 | 9.970 |
| Current Assets | 23.999 | 15.193 | 26.134 | 14.295 | 5.482 | 13.286 | 13.401 | 18.444 | 17.178 | 26.197 |
| Inventories | 21.053 | 4.667 | 7.380 | 6.703 | 3.532 | 3.478 | 3.615 | 4.331 | 5.444 | 4.105 |
| Receivables | 1.301 | 7.473 | 8.733 | 384 | 374 | 411 | 3.304 | 1.202 | 1.765 | 799 |
| Cash | 1.645 | 3.053 | 10.021 | 7.208 | 1.576 | 9.397 | 6.482 | 12.910 | 9.969 | 21.293 |
| Shareholders Funds | 7.655 | 11.279 | 21.898 | 11.069 | 17.277 | 21.850 | 26.871 | 33.941 | 23.348 | 31.388 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.344 | 3.914 | 4.236 | 3.227 | 6.468 | 3.694 | 12.992 | 5.498 | 8.311 | 4.779 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Pivalexim S.r.l.